Articles related to Hepatology

A growing body of observational evidence links coffee consumption with lower risks of several cancers, particularly hepatocellular and endometrial cancer, but experts caution that current data do not justify prescribing coffee as a cancer-prevention strategy.

A multicenter analysis of adults with biopsy-confirmed MASLD found that roughly one-quarter of cirrhosis cases developed before age 50, with type 2 diabetes and genetic susceptibility associated with earlier progression.

A 25-year-old man with approximately three years of daily high-volume energy drink consumption developed mixed-pattern liver injury with cholestatic histology. Exposure cessation coincided with substantial biochemical improvement, although causality remained uncertain and alternative explanations were not fully excluded.

U.S. News expanded its 2026-2027 hospital rankings with new regional specialty evaluations in cancer and cardiovascular care while increasing recognition for regional hospitals. Rankings continued to emphasize risk-adjusted mortality, preventable complications, patient experience, and objective outcomes measures.

Boehringer Ingelheim’s SYNCHRONIZE-1 phase 3 trial reported 16.6% average body weight reduction with survodutide, a dual GLP-1/glucagon receptor agonist, over 76 weeks in adults without type 2 diabetes.

A systematic review of five studies found no consistent short-term safety signals in renal, hepatic, or cardiometabolic outcomes among adolescents using creatine monohydrate.